Stratification of biological therapies by pathobiology in biologic-naive patients with rheumatoid arthritis (STRAP and STRAP-EU): two parallel, open-label, biopsy-driven, randomised trials
Felice Rivellese(Queen Mary University of London), Gina Tan(Queen Mary University of London), Juan D. Cañete(Hospital Clínic de Barcelona), James Galloway(King's College London), Arthur G. Pratt, Sabrina Raizada(New Cross Hospital), Giovanni Giorli(Queen Mary University of London), Anne Barton(University of Manchester), Louise Warren, Peter Sasieni(Queen Mary University of London), Deepak R. Jadon(University of Cambridge), Pier Paolo Sainaghi(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Alberto Cauli(University of Cagliari), Francesco Carlucci, Maya H Buch(Arthritis UK), Andrea Cuervo, Andrew Filer(Birmingham City University), Chris Holroyd(University Hospital Southampton NHS Foundation Trust), Edyta Jaworska(Queen Mary University of London), Michael R. Ehrenstein, Myles Lewis(Queen Mary University of London), Nagui Gendi(Basildon Hospital), Costantino Pitzalis(Queen Mary University of London), Pauline Ho(Manchester Royal Infirmary), Bhaskar Dasgupta(Anglia Ruskin University), Christopher D. Buckley(Queen Elizabeth Hospital Birmingham), Hector Chinoy(Salford Royal NHS Foundation Trust), Iain B. McInnes(University of Glasgow), Ernest Choy(Cardiff University), Christopher J Edwards(University Hospital Southampton NHS Foundation Trust), Cankut Çubuk(Queen Mary University of London), Patrick Durez(Cliniques Universitaires Saint-Luc), Joaquim Polido‐Pereira(University of Lisbon), Elisa Gremese(Università Cattolica del Sacro Cuore), Richard Stratton(The Royal Free Hospital), Chijioke H Mosanya, Debbie Maskall, Peter C. Taylor(Nuffield Orthopaedic Centre), Ana Rita Marinho Machado, Georgina Thorborn, Désirée van der Heijde(Leiden University Medical Center), Arti Mahto(King's College Hospital NHS Foundation Trust), Charlotte Rawlings, Neil D McKay(NHS Lothian), Ahmed S Zayat, Claire Gorman(Homerton University Hospital NHS Foundation Trust), Frances Humby(Queen Mary University of London), Nora Ng(Queen Mary University of London), Alessandra Nerviani(Queen Mary University of London)
Cited by 72
Related Papers
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
|Annals of the Rheumatic Diseases|2020|2.8k
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
|Annals of the Rheumatic Diseases|2022|1.9k
Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial
|The Lancet|2004|1.8k
2022 update
|Radboud Repository (Radboud University)|2010|1.6k
2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis
|Annals of the Rheumatic Diseases|2017|1.6k